Cavium, Inc. (CAVM) Shares Bought by Ameriprise Financial Inc.
Ameriprise Financial Inc. boosted its stake in shares of Cavium, Inc. (NASDAQ:CAVM) by 42.9% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 3,425,325 shares of the semiconductor provider’s stock after acquiring an additional 1,027,760 shares during the quarter. Ameriprise Financial Inc. owned approximately 4.98% of Cavium worth $225,867,000 as of its most recent SEC filing.
A number of other large investors also recently modified their holdings of the business. Solaris Asset Management LLC lifted its position in Cavium by 43.4% during the 2nd quarter. Solaris Asset Management LLC now owns 2,295 shares of the semiconductor provider’s stock valued at $143,000 after purchasing an additional 695 shares during the period. BNP Paribas Arbitrage SA lifted its position in Cavium by 107.3% during the 2nd quarter. BNP Paribas Arbitrage SA now owns 2,579 shares of the semiconductor provider’s stock valued at $160,000 after purchasing an additional 1,335 shares during the period. World Asset Management Inc acquired a new position in Cavium during the 3rd quarter valued at about $203,000. Tudor Investment Corp ET AL acquired a new position in Cavium during the 2nd quarter valued at about $228,000. Finally, Pacad Investment Ltd. lifted its position in Cavium by 42.3% during the 2nd quarter. Pacad Investment Ltd. now owns 3,700 shares of the semiconductor provider’s stock valued at $230,000 after purchasing an additional 1,100 shares during the period.
In other Cavium news, SVP Vincent P. Pangrazio sold 15,000 shares of the firm’s stock in a transaction that occurred on Friday, November 10th. The shares were sold at an average price of $77.22, for a total transaction of $1,158,300.00. Following the sale, the senior vice president now directly owns 60,039 shares in the company, valued at approximately $4,636,211.58. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, VP Anil Kumar Jain sold 8,500 shares of the firm’s stock in a transaction that occurred on Tuesday, November 21st. The stock was sold at an average price of $85.90, for a total transaction of $730,150.00. Following the sale, the vice president now owns 91,616 shares in the company, valued at $7,869,814.40. The disclosure for this sale can be found here. Company insiders own 4.65% of the company’s stock.
WARNING: This article was published by Watch List News and is the property of of Watch List News. If you are accessing this article on another domain, it was illegally stolen and republished in violation of United States & international copyright legislation. The original version of this article can be read at https://www.watchlistnews.com/cavium-inc-cavm-shares-bought-by-ameriprise-financial-inc/1722987.html.
Shares of Cavium, Inc. (CAVM) opened at $88.60 on Friday. The firm has a market cap of $6,127.20, a P/E ratio of 82.04, a P/E/G ratio of 3.20 and a beta of 1.27. The company has a debt-to-equity ratio of 0.81, a current ratio of 2.87 and a quick ratio of 2.27. Cavium, Inc. has a 52-week low of $53.76 and a 52-week high of $88.84.
Cavium (NASDAQ:CAVM) last announced its quarterly earnings results on Wednesday, November 1st. The semiconductor provider reported $0.76 earnings per share for the quarter, beating analysts’ consensus estimates of $0.74 by $0.02. The business had revenue of $251.99 million for the quarter, compared to the consensus estimate of $250.16 million. Cavium had a negative net margin of 19.94% and a positive return on equity of 11.16%. Cavium’s revenue for the quarter was up 49.9% on a year-over-year basis. During the same period last year, the company posted $0.43 EPS. research analysts predict that Cavium, Inc. will post 1.33 earnings per share for the current fiscal year.
CAVM has been the topic of a number of research reports. Zacks Investment Research upgraded shares of Cavium from a “hold” rating to a “buy” rating and set a $76.00 target price on the stock in a research report on Monday, November 6th. Canaccord Genuity upped their target price on shares of Cavium from $66.00 to $67.00 and gave the company a “hold” rating in a research report on Thursday, November 2nd. Morgan Stanley downgraded shares of Cavium from an “overweight” rating to an “equal weight” rating and set a $77.00 price target on the stock. in a research report on Tuesday. Raymond James Financial, Inc. reiterated an “outperform” rating and issued a $75.00 price target on shares of Cavium in a research report on Thursday, September 14th. Finally, KeyCorp reiterated a “hold” rating on shares of Cavium in a research report on Friday, September 1st. Twelve analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. Cavium has an average rating of “Hold” and a consensus price target of $80.71.
Cavium, Inc is a provider of integrated semiconductor processors that enable intelligent processing for wired and wireless infrastructure and cloud for networking, communications, storage and security applications. The Company’s products consist of multi-core processors for embedded and data center applications, network connectivity for server and switches, storage connectivity, and security processors for offload and appliance.
Receive News & Ratings for Cavium Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cavium Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.